Gladstone NOW: The Campaign Join Us on the Journey✕
106 - 120 of 339 Results Clear All
Nautilus—In the ongoing war on cancer, some scientists are taking a new approach—turning on the body’s own self defense system. Assistant Investigator Karin Pelka describes her team’s efforts to train the immune system to recognize and fight tumors.
Gladstone Experts Genomic Immunology Pelka Lab
Scientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.
Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.
Gladstone Experts COVID-19 Virology Roan Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, puts the CDC's definition of "fully vaccinated" in the context of our constantly evolving understanding of the COVID-19 pandemic.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.
Gladstone Experts COVID-19 Virology Roan Lab
USA Today—Senior investigator Warner Greene, MD, PhD, comments on the benefits of vaccination after COVID-19 illness.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab
ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab
San Francisco Business Times—Senior Investigator Katerina Akassoglou, PhD, was picked by the San Francisco Business Times as one of the most influential women in business in the Bay Area this year.
Gladstone Experts Center for Neurovascular Brain Immunology Akassoglou Lab Diversity
KALW—Gladstone President Deepak Srivastava, MD, is one of two Bay Area leaders in COVID-19 research discussing current progress in the development of novel treatment, prevention and detection methods, at Gladstone and in the Bay Area.
Gladstone Experts COVID-19 Cardiovascular Disease
Smithsonian Magazine—Associate Investigator Jeanne Paz, PhD, discusses her lab's recent discovery that C1q, a component of the immune system, mediates cognitive deficits after a traumatic brain injury and may lead to new ways to curb or prevent these deficits.
Gladstone Experts Traumatic Brain Injury Epilepsy Neurological Disease Paz Lab
Gladstone experts discuss waning immunity against COVID-19 and whether you'll need a booster shot
Gladstone Experts COVID-19
UCSF News—Associate Investigator Nadia Roan, PhD, explains why the coronavirus delta variant is so infectious, how antibodies and T cells contribute to immunity, and why vaccinated people should still wear masks.
Gladstone Experts COVID-19 Virology Roan Lab
Virus mutation and vaccination gap spur rise in cases nationwide
Gladstone Experts COVID-19
New York Times—The microbiome plays a role in many autoimmune conditions, and some scientists believe that fecal transplants from individuals living in non-industrialized cultures may provide a solution. Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, explains why it may not be that easy.
Gladstone Experts Autoimmune Diseases Data Science and Biotechnology Pollard Lab Microbiome
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, calls the Delta strain of the coronavirus, which originated in India, our biggest threat so far because it is rapidly spreading all over the world, and reminds us that other new strains may yet arise.
Gladstone Experts COVID-19 Greene Lab
